Financial, Advisory and Investors attending in 2016:

203 Investment Partners
Abingworth LLP
ACXIT Capital Partners
ACXIT Lifesciences GmbH
Advent Life Sciences
Affas Besse Advisors Ltd
Aglaia Oncology Fund
Albion Ventures LLP
Alpha Omega LLC
ALSTIN
Anterra Capital
apo Asset Management
Arix Bioscience
Arthurian Life Sciences Ltd.
Ascenion GmbH
Aureae Portae Enterprise Fund
BB Biotech Ventures
Bellevue Asset Management AG
Belsize Asset Management
Berenberg Bank
Bergmann zur Hausen & Cie. GmbH
Bio Medi Gene Ventures
BioBac BioValley Basel Buisness Angels Club
BioBac BioValley Basel Business Angels Club
BioMedPartners AG
BioStart Consulting GmbH
Biotech Alliances International, Inc.
Bird & Bird LLP
Bootstrap Europe
Breslin AG
Bristol-Myers Squibb
Brock Capital Group LLC
Capricorn One
Capricorn Venture Partners NV
CBT Advisors
ChinaBio Capital
Colpman Consulting Ltd.
Cooley LLP
Coulter Partners
Csendes Consulting
Cukierman & Co. Life Sciences
DAH
DDF Ventures
Deepbridge Capital LLP
Deutsche Bank AG
Edison Group
Edmond de Rothschild Investment Partners
Eminent Venture Capital Corporation / TaiAn Technologies
Ernst & Young
Ernst & Young AG
ETERCY
European Investment Fund
EVA - the Basel life sciences start-up agency
Excellentia Global Partners
F. Hoffmann-La Roche AG Roche Venture Fund
FastVentures B.V.
Forbion Capital Partners
FORMED Ventures
Fraser Finance

fundamenta CAPITAL AG
Gilde Healthcare Partners
Global Life Science Ventures
Global Life Science Ventures AG
Global Strategic Medical
goetzpartners holding
Grabulovski Consulting Services
Gurnet Point Capital
Hadasit Incubator
HBM Partners AG
Health Advances GmbH
HealthCare Royalty Partners
Healthy Assets
High-Tech Gruenderfonds Management GmbH
IBB Beteiligungsgesellschaft GmbH
ICF Consult
IMI Consulting GmbH
Imperial Innovations
Indelve
Independent Biotech Advisor
Independent Consultant
Industrifonden
INKEF Capital BV
INSERM DR GRAND EST
Inserm Transfert
Inserm Transfert Initiative
Inveready
Invest Securities
IPF Partners
Jefferies International Limited
JJ Zwicky & Partners
JP Morgan Healthcare
JPI Funds
Kalliste Biotech Fund
Karolinska Development AB
Katan Associates, Inc.
Katan Family Office
Kinled Holding
Kreos Capital
Kurma Partners
LifeCare Partners
LifeSci Advisors
LSP
LSVenture GmbH
Martina Kaufmann Strategic Consulting
MBS Value Partners
Medical Strategy GmbH
medicxi
MedTech Innovation Partners AG
MedVenture Partners GmbH
Merck Ventures
Merieux Developpement
Mid Atlantic Bio Angels
Mirabaud Securities LLP
MPM Capital
MS Ventures
MVM Life Science Partners LLC
Nasdaq OMX
Neomed
NetScientific PLC

New Enterprise Associates
New Science Global Healthcare Fund
Nextech Invest Ltd.
NLS Pharma Group
Norgine Ventures
NovaSecta Ltd.
Novo Seeds
NRW Bank
Office of Economy and Labour
Omega Funds
Oncology Venture
Oxford University Innovation
PharmaVentures Ltd.
Philimmune, LLC
Pierre Fabre Fund for Innovation
PM Equity Partner
Positive Capital
Privateq Advisors AG
PwC
Redalpine Venture Partners
RMI Partners
Roche Partnering
Roundcape Ltd.
Royal Bank of Canada (Suisse)
S.R.One, Limited
Salus Partners
Seventure Partners
Silicon Valley Bank
Sirius Healthcare Partners
Sofinnova Partners
Stifel Financial Corp.
Stratos Bio
Suda Ltd.
Sunstone Capital A/S
SV Associates
SV Life Sciences
SymbioSwiss
Takeda Ventures, Inc.
The Fulford Group
TheraVenture GmbH
Torreya Partners (Europe), LLC
Torreya Partners, LLC
TVM Capital
TVM Capital China Limited
Umblin
UP Biotech Management AG
valuationLAB AG
Ventac Partners GmbH
Venture Valuation AG / Biotechgate
Versant Ventures
VI Partners AG
VIRETUM CONSULT
Visium Asset UK LLP
Vogel BioC
WBB Capital
Wellington Partners
XOventure GmbH
Yorkville Advisors, LLC
Zukunftsfonds Heilbronn GmbH & Co KG